{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:10:39Z","timestamp":1791090639763,"version":"4.1.0"},"reference-count":61,"publisher":"American Society for Microbiology","issue":"13","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>CD8<jats:sup>+<\/jats:sup>T lymphocytes have been shown to be involved in controlling poxvirus infection, but no protective cytotoxic T-lymphocyte (CTL) epitopes are defined for variola virus, the causative agent of smallpox, or for vaccinia virus. Of several peptides in vaccinia virus predicted to bind HLA-A2.1, three, VETFsm(498-506), A26L(6-14), and HRP2(74-82), were found to bind HLA-A2.1. Splenocytes from HLA-A2.1 transgenic mice immunized with vaccinia virus responded only to HRP2(74-82) at 1 week and to all three epitopes by ex vivo enzyme-linked immunosorbent spot (ELISPOT) assay at 4 weeks postimmunization. To determine if these epitopes could elicit a protective CD8<jats:sup>+<\/jats:sup>T-cell response, we challenged peptide-immunized HLA-A2.1 transgenic mice intranasally with a lethal dose of the WR strain of vaccinia virus. HRP2(74-82) peptide-immunized mice recovered from infection, while nai\u0308ve mice died. Depletion of CD8<jats:sup>+<\/jats:sup>T cells eliminated protection. Protection of HHD-2 mice, lacking mouse class I major histocompatibility complex molecules, implicates CTLs restricted by human HLA-A2.1 as mediators of protection. These results suggest that HRP2(74-82), which is shared between vaccinia and variola viruses, may be a CD8<jats:sup>+<\/jats:sup>T-cell epitope of vaccinia virus that will provide cross-protection against smallpox in HLA-A2.1-positive individuals, representing almost half the population.<\/jats:p>","DOI":"10.1128\/jvi.78.13.7052-7060.2004","type":"journal-article","created":{"date-parts":[[2004,6,11]],"date-time":"2004-06-11T21:18:16Z","timestamp":1086988696000},"page":"7052-7060","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":86,"title":["Protection against Lethal Vaccinia Virus Challenge in HLA-A2 Transgenic Mice by Immunization with a Single CD8<sup>+<\/sup>T-Cell Peptide Epitope of Vaccinia and Variola Viruses"],"prefix":"10.1128","volume":"78","author":[{"given":"James T.","family":"Snyder","sequence":"first","affiliation":[{"name":"Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1578"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor M.","family":"Belyakov","sequence":"additional","affiliation":[{"name":"Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1578"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amiran","family":"Dzutsev","sequence":"additional","affiliation":[{"name":"Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1578"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc\u0327ois","family":"Lemonnier","sequence":"additional","affiliation":[{"name":"Institut Pasteur, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay A.","family":"Berzofsky","sequence":"additional","affiliation":[{"name":"Vaccine Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1578"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.2174\/1566524033479843"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/13.7.897"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200113463"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.4049\/jimmunol.158.8.3947","volume":"158","year":"1997","unstructured":"Ahlers, J. D., N. Dunlop, D. W. Alling, P. L. Nara, and J. A. Berzofsky. 1997. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: GM-CSF and TNF\u03b1 synergize with IL-12 to enhance induction of CTL. J. Immunol.158:3947-3958.","journal-title":"J. Immunol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1998.9123"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5102"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(04)00053-6"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.4.1709"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1233578100"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI20261"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1201-1320"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.8.4512"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200112)31:12<3557::AID-IMMU3557>3.0.CO;2-O"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/35105075"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1999.tb01336.x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.5.12.3403-3409.1985"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.7.1221"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.262668999"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/378518"},{"key":"e_1_3_2_21_2","first-page":"1639","volume":"300","year":"2003","unstructured":"Enserink, M. 2003. Infectious diseases. U. S. monkeypox outbreak traced to Wisconsin pet dealer. Science300:1639.","journal-title":"Science"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(2001010)31:10<3064::AID-IMMU3064>3.0.CO;2-L"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830040202"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(90)90294-2"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80295-2"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm917"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.2.910-915.1995"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/369031a0"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.143.2.450"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/255552a0"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830050405"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(88)90115-8"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1201-1271"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196911272812201"},{"key":"e_1_3_2_35_2","first-page":"461","volume":"3","year":"2003","unstructured":"Larkin, M. 2003. Monkeypox spreads as US public-health system plays catch-up. Lancet Infect. Dis.3:461.","journal-title":"Lancet Infect. Dis."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1086\/376557"},{"key":"e_1_3_2_37_2","first-page":"6","volume":"3","year":"1987","unstructured":"Mayr, A., V. Hochstein-Mintzel, and H. Stickl. 1987. Origin, properties and use of the attenuated vaccinia strain MVA. Z. Klin. Ther. Infekt.3:6-14.","journal-title":"Z. Klin. Ther. Infekt."},{"key":"e_1_3_2_38_2","first-page":"373","volume":"167","year":"1978","unstructured":"Mayr, A., H. Stickl, H. K. Muller, K. Danner, and H. Singer. 1978. The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism. Zentbl. Bakteriol. Hyg. Abt 1 Orig. B167:373-390.","journal-title":"Zentbl. Bakteriol. Hyg. Abt 1 Orig. B"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.4049\/jimmunol.156.7.2473","volume":"156","year":"1996","unstructured":"Newberg, M. H., D. H. Smith, S. B. Haertel, D. R. Vining, E. Lacy, and V. H. Engelhard. 1996. Importance of MHC class 1 \u03b12 and \u03b13 domains in the recognition of self and non-self MHC molecules. J. Immunol.156:2473-2480.","journal-title":"J. Immunol."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830230603"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-74-7-1409"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0630592100"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.5.2548"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.152.1.163","volume":"152","year":"1994","unstructured":"Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol.152:163-175.","journal-title":"J. Immunol."},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.4049\/jimmunol.149.11.3580","volume":"149","year":"1992","unstructured":"Parker, K. C., M. A. Bednarek, L. K. Hull, U. Utz, B. Cunningham, H. J. Zweerink, W. E. Biddison, and J. E. Coligan. 1992. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J. Immunol.149:3580-3587.","journal-title":"J. Immunol."},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.12.2043"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(90)90296-4"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.18.8166"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0398-321"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0706.010602"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000315)85:6<829::AID-IJC16>3.0.CO;2-K"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00375376"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI3714"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/351323a0"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.1.23"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.22.10847"},{"key":"e_1_3_2_57_2","first-page":"195","volume":"84","year":"1995","unstructured":"Sutter, G., and B. Moss. 1995. Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus. Dev. Biol. Stand.84:195-200.","journal-title":"Dev. Biol. Stand."},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(92)90752-B"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20022222"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0320(20000301)39:3<189::AID-CYTO3>3.0.CO;2-C"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.4.1007"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm916"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.78.13.7052-7060.2004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.78.13.7052-7060.2004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T21:09:11Z","timestamp":1682716151000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.78.13.7052-7060.2004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":61,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1128\/JVI.78.13.7052-7060.2004"],"URL":"https:\/\/doi.org\/10.1128\/jvi.78.13.7052-7060.2004","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"2003-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-03-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}